> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Outsourcing Facility Registration
- URL: https://www.fdaweb.com/comments-sought-on-outsourcing-facility-registration/
- Published: 2017-06-20T12:00:00.000Z
- Updated: 2026-09-14T22:30:29.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138972

*Federal Register* notice: FDA is seeking comments on the information collection requirements in its “Guidance for Industry on Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act: OMB Control Number 0910–0777\. A facility that compounds drugs may elect to register with FDA as an outsourcing facility under section 503B of the FD&C Act (21 U.S.C. 353b). These facilities must also re-register annually between 10/1 and 12/31\. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-06-20/pdf/2017-12838.pdf?ref=fdaweb.com).